Epithelial to mesenchymal transition in mammary tissue and anti metastasis therapy by Bataller González, Judit & Universitat Autònoma de Barcelona. Facultat de Biociències
EPITHELIAL TO MESENCHYMAL TRANSITION IN MAMMARY TISSUE AND ANTI 
METASTASIS THERAPY 
JUDIT BATALLER GONZALEZ 
UNIVERSITAT AUTONOMA DE BARCELONA 
Judit.bataller@e-campus.uab.cat 
 
The topic was chosen due to the importance of EMT over an individual’s lifetime, and 
specifically in mammary tissue for the incidence of breast cancer nowadays. To make known 
the possible anti metastasis therapies, could give an encouraging view to keep investigating in 
this field.  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
• Epithelial cells in the epiblast layer express E-cadherin and exhibit apical basal 
polarity.  
• During mammary development Wnt, Notch and Hedgehog pathways are activated.  
• The epithelial cells that line the mammary gland establish an AB axis with apical and 
basal surface and specialized junctions are formed along the lateral membrane. The 
junctional localization of E-cadherin and β-catenin is crucial for the cell-cell and ECM-
cell contacts.   
• The sustained balance of polarity signaling is crucial for the continued maintenance 
of AB polarity.  
 
DEVELOPMENT 
TYPE I EMT 
 
• The process of wound healing involves the orchestred activities of cell types to 
facilitate the re-epithelization of denuded areas. 
• The key cells involved in the repair of damaged epithelium are myofibroblasts, and 
signaling by TGF-β and ECM are essential in promoting the activation and 
differentiation of myofibroblasts.  
• The completion of EMT is typically assessed by α-SMA expression in fully 
transitioned cells and its expression is indicative of a fibrotic state. α-SMA  
expression is induced by TGF-β and integrin activation cooperates with TGF-β to 
induce EMT and myofibroblasts activation. 
•  TGF-β signaling supports chronic inflammatory reactions that promote 
fibroproliferative disorders in humans.  
REGENERATION  
TYPE II EMT 
ANTI METASTASIS 
THERAPY 
       RESULTS AND DISCUSSION       
 
 EMT IN BREAST CANCER 
In breast cancer progression, imbalances in the AB 
polarity network weaken tight junctions. There are 
several pathways, such as TGF-β which promotes 
survival and cell cycle progression destabilizing the 
contacts between cells. Transcription Factor ZEB1 
activates the mTOR pathway which is deregulated in 
breast cancer. 
  
 
 
 
 
 
 
 
A central target to the EMT signaling pathway is E-cadherin, the 
main protein involved in adherens  junctions, classified as a 
tumor suppressor. It can be perturbed at multiple levels and this 
is central to polarity changes associated with EMT. Snail is the 
first direct transcriptional repressor of E-Cadherin, but Slug and 
Twist are also EMT inducers in cancer cells. The expression of 
these three correlates with aggressive disease, reinforcing the 
effects of an oncogenic EMT.  
 
Polarity switching in breast cancer development. (From Goode NJ 
et al. 2010 [1]). 
Genes and pathways missexpressed in breast cancer 
include Cripto-1, Snail/Slug/Twist, Wnt and TGF-β 
signaling. Collective migration of the tumor cells sets the 
stage for metastatic dissemination to distant organ sites 
in late stage breast cancer. (From Micalizzi DS, et al. 2010 
[3]). 
Developmental EMT signaling pathways reactivated in Breast Cancer 
 
 
Wnt signaling pathway 
 
In the presence of Wnt ligands, β-catenin translocates into the nucleus 
regulating the transcription of Wnt target genes. GSK3β not only 
regulates β-catenin but also mediates proteosomal degradation of 
Snail. Inhibition of GSK3β leads to accumulation of Snail which 
represses E-cadherin. Therefore, Wnt can stabilize the levels of Snail 
and β-catenin.  
The mammary tissue is an epithelial tissue 
in which the cells are in contact with each 
other and with the ECM. It is very 
important to maintain these contacts for 
the integrity of the tissue. If by different 
mechanisms these contacts are lost, cells 
acquire a migratory capacity with an 
invasion of other tissues.   
The EMT phenomenon is a process that 
allows the cells to lose their contacts. 
Therefore, the epithelial cells become 
mesenchymal cells.  
Epithelial Mesenchymal Transition phenomenon. (From 
Scott F. Gilbert, 2010 [2]) 
Wnt signaling pathway 
reactivated in Breast Cancer 
Notch signaling pathway 
The Notch signaling pathway plays an important role in maintaining the progenitor cell population. This 
pathway is coordinated with others to regulate EMT such as TGF-β pathway. Elevated Jagged 1(Notch 
ligand) and Notch promote Slug expression, thereby repressing E-cadherin. Moreover, there is a 
crosstalk between Notch and Wnt pathways. Wnt1 transforms primary human mammary epithelial 
cells, and these cells have Delta ligand expression.  
 
PROSTAGLANDIN 
 
TRANSGLUTAMINASE 2 
 
 
 
 
 
 
 
 
 
 
Inhibition of TG2 by small-molecule inhibitors, 
antisense RNA or siRNA could render cancer 
cells sensitive to chemotherapeutic drugs.  
 
 
miRNA-375 
 
 
 
 
 
 
 
 
 
 
 
Re-expression of miRNA-375 or inhibition of 
MTDH might be potential therapeutic 
approaches for the treatment of Tamoxifen-
resistant breast cancer in future.  
 
 
                                           SPHINGOSINE KINASE 
 
 
 
 
 
 
 
 
 
 
 
SKI-II can be an effective ER antagonist in the 
setting of Tamoxifen resistance making SKI-II an 
attractive therapeutic candidate for the treatment 
of ER-positive breast cancer.  
 
• The epithelial mesenchymal transition phenomenon is crucial for the embryonic developmental processes as   
well as wound healing and cancer. 
• It is very important for the cells that undergo an EMT to lose cell-cell and ECM-cell contacts in order to 
establish the mesenchymal phenotype that    allows them to migrate and expand within distant tissues.  
• Studies reveal several anti-metastatic therapies that could reverse the epithelial mesenchymal transition. The 
molecules involved are Prostaglandin E2, Transglutaminase 2, microRNA-375 and sphingosine kinase.  
 
The aim of this literature review is to make known the EMT phenomenon in mammary tissue and its importance in the development, wound healing and cancer. In addition, evidence of possible anti 
metastasis therapies which could reverse EMT is given.  
There are 4 types of EP receptors  with different 
intracellular signaling pathways, so some 
receptors contribute to tumor progression and 
others may be protective. As the role of each 
receptor in cancer grows, selective EP agonists 
and antagonists could be exploited as therapeutic 
targets.  
MATERIALS AND METHODS 
 
Breast cell cultures, murine models, mutant constructs and Breast cancer cell lines have been 
used to achieve the results exposed.  
High quality journals and books have also been used as reference for this literature review. The 
articles and reviews related to the EMT in the mammary tissue have been selected to give a 
general view of the processes involved.  
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